233 related articles for article (PubMed ID: 30025095)
1. Hyperreflective Foci Number Correlates with Choroidal Neovascularization Activity in Angioid Streaks.
Parodi MB; Arrigo A; Romano F; Aragona E; Marchese A; Cicinelli MV; Mercuri S; Bandello F
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3314-3319. PubMed ID: 30025095
[TBL] [Abstract][Full Text] [Related]
2. Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks.
Sekfali R; Mimoun G; Cohen SY; Querques G; Bandello F; Sacconi R; Souied EH; Capuano V
Eur J Ophthalmol; 2020 May; 30(3):550-556. PubMed ID: 30880436
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study.
Iacono P; Battaglia Parodi M; La Spina C; Bandello F
Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.
Tetikoglu M; Sagdik HM; Aktas S; Ozcura F
Eye (Lond); 2016 Jun; 30(6):894-5. PubMed ID: 26939555
[No Abstract] [Full Text] [Related]
5. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study.
Rosina C; Romano M; Cigada M; de Polo L; Staurenghi G; Bottoni F
Eur J Ophthalmol; 2015; 25(1):47-50. PubMed ID: 25044143
[TBL] [Abstract][Full Text] [Related]
6. Identification of hyperreflective foci in angioid streaks.
Romano F; Mercuri S; Arrigo A; Marchese A; Cicinelli MV; Albertini GC; Bandello F; Battaglia Parodi M
Eye (Lond); 2019 Dec; 33(12):1916-1923. PubMed ID: 31278381
[TBL] [Abstract][Full Text] [Related]
7. Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.
Diago T
Eye (Lond); 2016 Apr; 30(4):637-9. PubMed ID: 26795418
[No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.
Battaglia Parodi M; Iacono P; La Spina C; Berchicci L; Scotti F; Leys A; Introini U; Bandello F
Am J Ophthalmol; 2014 Feb; 157(2):374-377.e2. PubMed ID: 24211865
[TBL] [Abstract][Full Text] [Related]
9. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal aflibercept for management of choroidal neovascularization secondary to angioid streaks : The Italian EYLEA-STRIE study.
Parodi MB; Cicinelli MV; Marchese A; Giuffrè C; Viola F; Staurenghi G; Varano M; Bandello F
Eur J Ophthalmol; 2021 May; 31(3):1146-1153. PubMed ID: 32483995
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal aflibercept for choroidal neovascularization in ocular sarcoidosis.
Querques L; Querques G; Miserocchi E; Modorati G; Bandello F
Eur J Ophthalmol; 2016 Aug; 26(5):e124-7. PubMed ID: 26868005
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
[TBL] [Abstract][Full Text] [Related]
15. INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS.
Alagöz C; Alagöz N; Özkaya A; Çelik U; Turan MF; Yazici AT; Çekiç O; Demirok A
Retina; 2015 Oct; 35(10):2001-10. PubMed ID: 25996427
[TBL] [Abstract][Full Text] [Related]
16. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
[TBL] [Abstract][Full Text] [Related]
18. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS.
Kim J; Dalziel D
Retin Cases Brief Rep; 2021 May; 15(3):246-250. PubMed ID: 30048402
[TBL] [Abstract][Full Text] [Related]
19. Fluorescein Leakage and Optical Coherence Tomography Features of Choroidal Neovascularization Secondary to Pathologic Myopia.
Battaglia Parodi M; Iacono P; Romano F; Bandello F
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3175-3180. PubMed ID: 30025121
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
